Table 1.
rs12959006 | N | CDMS | N | Relapse | N | ΔEDSS |
---|---|---|---|---|---|---|
CC | 41 | Ref | 70 | Ref | 37 | 0.26 (0.20, 0.32) |
CT + TT | 27 | 1.57 (0.93, 2.64) | 82 | 1.74 (1.19, 2.56) | 24 | +0.18 (0.06, 0.30) |
p = .09 | p = .005 | p = .004 |
HR, hazard ratio; CI, confidence interval; β, beta coefficient; EDSS, Expanded Disability Status Scale; FDE, first demyelinating event.
Due to the small number people carrying TT genotype who converted to CDMS (N = 2), we recoded the genotype as CT + TT. Genotype CC was used as reference in the analysis. Results were adjusted for age, sex and study site, and presented as HR (95% CI) for time to CDMS and relapse. Disability results are presented as geometric mean annualized disability progression (95% CI) for the reference group, whereas coefficient relative to reference (β [95% CI]) are presented for subsequent levels. N refers to the number of events for each related clinical course. p value <0.05 bolded.